Skip to main
  1. Stocks
  2. MetLife
  3. Forecast
MET

MetLife (MET) Stock Forecast & Price Target

MetLife (MET) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 58%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

MetLife is positioned for durable fundamental strength because its scale, diversified mix, and disciplined execution support earnings growth that can outpace revenue, aided by AI-driven efficiencies and operating leverage. Its U.S. Group Benefits and RIS franchises together contribute about 52% of 2025 adjusted earnings, while Asia adds roughly 25% and Latin America about 14% of 2024 earnings, giving the company multiple growth engines with relatively low macro sensitivity. The business mix is shifting toward higher-ROE, capital-light segments, and with adjusted ROE at 16% in 2025 and 17% in 1H26, the company appears well positioned to sustain attractive profitability and capital returns.

Bears say

MetLife is vulnerable to earnings volatility because its investment portfolio and alternative asset returns can swing with market conditions, and a reversal of the strong variable investment tailwinds seen in 2Q26 could quickly pressure results. Its profitability is also exposed to lower long-term interest rates, credit spread changes, and slower wage or employment growth, which could weaken pension risk transfer activity, increase liability instability, and hurt the company’s core US franchises that drive about 52% of 2025 adjusted earnings. In addition, heavy exposure to international markets and intense global competition raise the risk of FX headwinds, regulatory pressure, fee compression, and mortality normalization, which could undermine the Asia, Latin America, and EMEA earnings base.

MetLife (MET) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 58% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MetLife and is not a guaranteed prediction by Public.com or investment advice.

MetLife (MET) Analyst Forecast & Price Prediction

Get the latest MetLife (MET) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MetLife (MET)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MetLife (MET) Forecast

Analysts have given MetLife (MET) a Buy based on their latest research and market trends.

According to 12 analysts, MetLife (MET) has a Buy consensus rating as of Oct 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $108.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $108.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MetLife (MET)


MetLife (MET) Analyst Forecast & Price Prediction

Get the latest MetLife (MET) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MetLife (MET)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MET stock data and trends